MedPath

Syph-Check Syphilis Antibody Point of Care (POC) Test

Terminated
Conditions
Screening for Syphilis Infections
Interventions
Device: Syph-Check POC
Registration Number
NCT00732355
Lead Sponsor
Healthcare Providers Direct, Inc.
Brief Summary

The study is designed to evaluate the performance of a rapid membrane test in a clinic or doctor's office setting to identify potential patients infected with syphilis and compare the results to currently licensed laboratory based tests.

Detailed Description

The overall objectives of this study are to determine the performance characteristics of a candidate rapid point-of-care test (Syph-Check cassette format) for Treponema pallidum antibodies in serum, plasma and finger stick whole blood obtained from females and males attending sexually transmitted diseases (STD) clinics, family planning / reproductive health clinics, and physician's office; and to compare the performance of this new, rapid test to currently licensed laboratory based tests, the non-treponemal RPR and a Treponemal ELISA or TPPA test.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Men and Women will be eligible who:

    1. are 18 years of age or older;
    2. Routine "presumed uninfected" for screening visit, or show symptomatic signs of infection or are asymptomatic but are suspected of infection, and either/or have other STD disease conditions and infections, will be identified.
    3. Pregnant women in the first and third trimester
Exclusion Criteria
  • are under 18 years of age
  • unwillingness to give consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
USyph-Check POCpresumed uninfected patients
ISyph-Check POCknown syphilis infected patients
Primary Outcome Measures
NameTimeMethod
Identify the sensitivity and specificity of the POC test versus accepted laboratory testsend of study
Secondary Outcome Measures
NameTimeMethod
Percent positive agreement data will include supplemental test results identified by infection categories and treatment as possibleend of study

Trial Locations

Locations (1)

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath